Found 7 results
Author Title [ Type(Desc)] Year
Filters: Author is Danis, R  [Clear All Filters]
Conference Paper
L. D. Hubbard, Danis, R., Neider, M., Wabers, H., and Thayer, D., Brightness, Contrast, and Color Balance of Digital vs. Film Retinal Images in the Age-Related Eye Disease Study 2, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
Journal Article
E. Y. Chew, Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., and Ferris, F. L., The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report No. 1), Ophthalmology, vol. 119, pp. 2282-2289, 2012.
M. Davis, Sheetz, M., Aiello, L., Milton, R., Danis, R., Zhi, X., Girach, A., Jimenez, M., Vignati, L., and Group, P. K. C. - D. R. S. Study, Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-Standing Diabetic Macular Edema, Invest Ophthalmol Vis Sci, vol. 50, pp. 1-4, 2009.
A. Domalpally, Danis, R., Agron, E., Blodi, B., Clemons, T. E., and Chew, E., Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11., Ophthalmology, vol. 123, no. 11, pp. 2401-2407, 2016.
E. Chew, Kim, J., Sperduto, R., ,, Coleman, H., Thompson, D., Milton, R., Clayton, J., Hubbard, L., Danis, R., and , Evaluation of the Age-Related Eye Disease Study Clinical Lens Grading System AREDS Report No. 31, Ophthalmology, vol. 117, pp. 2112-2119.e3, 2010.
E. Chew, Clemons, T. E., SanGiovanni, J. P., Danis, R., Ferris, F. 3rd, Elman, M., Antoszyk, A., Ruby, A., Orth, D., Bressler, S., Fish, G., Hubbard, G., Klein, M., Chandra, S., ,, and Sperduto, R., Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-149, 2014.
A. Girach, Aiello, L., Milton, R., Davis, M., Danis, R., Zhi, X., Sheetz, M., and Vignati, L., Sustained Moderate Visual Loss as a Predictive End Point for Visual Loss in Non-Proliferative Diabetic Retinopathy, Eye (Lond), vol. 23, pp. 209-214, 2009.